FilingReader Intelligence
Concord Biotech gets EU GMP clearance for API facility
August 21, 2025 at 08:59 AM UTC•By FilingReader AI
Concord Biotech Limited received EU Good Manufacturing Practice clearance for its Active Pharmaceutical Ingredients manufacturing facility in Limbassi following an inspection from August 18-21, 2025.
The approval enables Concord Biotech to expand into EU markets and strengthens its international presence in pharmaceutical ingredients manufacturing.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:CONCORDBIO•Bombay Stock Exchange
News Alerts
Get instant email alerts when Concord Biotech publishes news
Free account required • Unsubscribe anytime